Literature DB >> 32383572

Dance improves symptoms, functional mobility and fine manual dexterity in people with Parkinson disease: a quasi-experimental controlled efficacy study.

Hewa H Kalyani1,2,3, Karen A Sullivan4,5, Gene M Moyle6, Sandra G Brauer7, Erica R Jeffrey8,9, Graham K Kerr10,11.   

Abstract

BACKGROUND: Clinically, individuals diagnosed with Parkinson disease (PD) present several symptoms that impact on their functional independence and quality of life. While there is accumulating evidence supporting dance as an effective symptom management option, few studies have objectively assessed these benefits, particularly related to the Dance for Parkinson's Disease<sup>®</sup> (DfPD<sup>®</sup>) program. AIM: The aim of this study was to explore the effects of DfPD<sup>®</sup>-based dance classes on disease-related symptoms, fine-manual dexterity and functional mobility in people with PD.
DESIGN: A quasi-experimental controlled efficacy study, with pre and post testing of two parallel groups (dance versus control).
SETTING: Community. POPULATION: Thirty-three participants with PD allocated to one of two groups: dance group (DG; N.=17; age=65.8±11.7 years) or control group (CG: N.=16; age=67.0±7.7 years). They were cognitively intact (Addenbrooke's Score: DG=93.2±3.6, CG=92.6±4.3) and in early-stage of disease (Hoehn & Yahr: DG=1.6±0.7, CG=1.5±0.8).
METHODS: The DG undertook a one-hour DfPD<sup>®</sup>-based class, twice weekly for 12 weeks. The CG had treatment as usual. Both groups were assessed at baseline and after 12 weeks on disease-related symptom severity (MDS-Unified Parkinson Disease Rating Scale: MDS-UPDRS), fine-manual dexterity (Perdue Peg Board), measures of functional mobility (Timed Up & Go: single & dual task, Tinetti, Berg, Mini-BESTest) and self-rated balance and gait questionnaires (Activities Balance Confidence Scale: ABC-S; Gait and Falls: G&F-Q; Freezing of Gait: FOG).
RESULTS: Compared to the CG, there was significantly greater improvement in the DG pre-post change scores on measures of symptom severity MDS-UPDRS, dexterity, six measures of functional mobility, and the ABC-S, G&F-Q, FOG questionnaires.
CONCLUSIONS: DfPD<sup>®</sup>-based dance classes improved disease-related symptom severity, fine-manual dexterity, and functional mobility. Feasibility of the approach for a large scale RCT was also confirmed. CLINICAL REHABILITATION IMPACT: DfPD<sup>®</sup> could be an effective supportive therapy for the management of symptoms and functional abilities in PD.

Entities:  

Mesh:

Year:  2020        PMID: 32383572     DOI: 10.23736/S1973-9087.20.06069-4

Source DB:  PubMed          Journal:  Eur J Phys Rehabil Med        ISSN: 1973-9087            Impact factor:   2.874


  4 in total

Review 1.  Interventions for preventing falls in Parkinson's disease.

Authors:  Natalie E Allen; Colleen G Canning; Lorena Rosa S Almeida; Bastiaan R Bloem; Samyra Hj Keus; Niklas Löfgren; Alice Nieuwboer; Geert Saf Verheyden; Tiê P Yamato; Catherine Sherrington
Journal:  Cochrane Database Syst Rev       Date:  2022-06-06

2.  Managing freezing of gait in Parkinson's disease: a systematic review and network meta-analysis.

Authors:  Jojo Yan Yan Kwok; Robert Smith; Lily Man Lee Chan; Leo Chun Chung Lam; Daniel Yee Tak Fong; Edmond Pui Hang Choi; Kris Yuet Wan Lok; Jung Jae Lee; Man Auyeung; Bastiaan R Bloem
Journal:  J Neurol       Date:  2022-03-04       Impact factor: 6.682

3.  Physical Therapist Management of Parkinson Disease: A Clinical Practice Guideline From the American Physical Therapy Association.

Authors:  Jacqueline A Osborne; Rachel Botkin; Cristina Colon-Semenza; Tamara R DeAngelis; Oscar G Gallardo; Heidi Kosakowski; Justin Martello; Sujata Pradhan; Miriam Rafferty; Janet L Readinger; Abigail L Whitt; Terry D Ellis
Journal:  Phys Ther       Date:  2022-04-01

4.  Rhythmic cueing, dance, resistance training, and Parkinson's disease: A systematic review and meta-analysis.

Authors:  Claire Chrysanthi Karpodini; Petros C Dinas; Efthalia Angelopoulou; Matthew A Wyon; Aline Nogueira Haas; Maria Bougiesi; Sokratis G Papageorgiou; Yiannis Koutedakis
Journal:  Front Neurol       Date:  2022-08-09       Impact factor: 4.086

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.